We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TLV:BVBBanca Transilvania SA Analysis

Data as of 2026-07-29 - not real-time

RON 37.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Banca Transilvania is trading at RON 37.5, comfortably above its 20‑day (36.41), 50‑day (34.55) and 200‑day (30.23) moving averages, indicating a bullish price backdrop despite a modestly high RSI of 63.6. The stock’s PE of 9.6 is well below the industry average of 18.2, suggesting a valuation advantage, while the dividend yield of 3.0% with a 46.9% payout ratio adds income appeal. Fundamentally, the bank delivers strong profitability – operating margin 47.7% and profit margin 41.7% – and a robust ROE of 23.2%, supported by a 15.2% revenue growth year‑over‑year. However, operating cash flow is negative (‑21 bn RON) and free cash flow is flat, which tempers the cash‑rich balance sheet (cash 15.7 bn RON vs debt 20.6 bn RON). Technical signals are mixed: a bearish MACD crossover and decreasing volume hint at short‑term pressure, while the 30‑day volatility of 25% and a low beta (~0.5) point to moderate market sensitivity. The current price sits near the 52‑week high (38.28) and above analyst median target (34.71), limiting upside potential in the near term. Overall, the stock presents a blend of value and growth traits, with a solid dividend but some cash‑flow concerns that investors should monitor.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD crossover with shrinking histogram
  • Decreasing trading volume relative to 10‑day average
  • Price trading near resistance at 38.28 RON limiting upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Low PE (9.6) versus industry average (18.2)
  • Strong operating margin (47.7%) and ROE (23.2%)
  • Attractive dividend yield (3.0%) with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent revenue growth (15.2% YoY) and high profitability
  • Net cash position (cash exceeds debt) providing balance‑sheet resilience
  • Regional market leadership and diversified product suite

Key Metrics & Analysis

Financial Health

Revenue Growth15.20%
Profit Margin41.66%
P/E Ratio9.6
ROE23.17%
ROA2.27%
P/B Ratio2.0
Op. Cash FlowRON-21004752896
Industry P/E18.2

Technical Analysis

TrendBullish
RSI63.6
SupportRON 34.52
ResistanceRON 38.28
MA 20RON 36.41
MA 50RON 34.55
MA 200RON 30.23
MACDBearish
VolumeDecreasing
Fear & Greed Index88.88

Valuation

Target PriceRON 33.03
Upside/Downside-11.93%
GradeFair
TypeBlend
Dividend Yield3.03%

Risk Assessment

Beta0.01
Volatility25.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.